InvestorsHub Logo
Followers 832
Posts 119984
Boards Moderated 17
Alias Born 09/05/2002

Re: hovacre post# 83700

Monday, 10/22/2018 5:00:23 PM

Monday, October 22, 2018 5:00:23 PM

Post# of 108192
A cynic might say that NTGN designed the NEO-PV-1 trial as they did because they did not expect any single-agent activity, based on preclinical data.

My subjective pronouncement in #msg-143669591 remains, at least for now.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News